N/A
Completed N=12
PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention
Source: ClinicalTrials.gov NCT02373852 ↗Enrolled (actual)
12
Serious AEs
8.3%
Results posted
Sep 2019
Primary outcomePrimary: Number of Participants With Adverse Events During the Procedure and up to 30 Days Following Procedure — 5 Participants
Summary
The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Adverse Events During the Procedure and up to 30 Days Following Procedure |
5 | — |
| PRIMARY Number of Patients That Undergo Successful SVG Procedure |
12 | — |
Eligibility Criteria
Inclusion Criteria
- Patients underwent percutaneous intervention (PI) of SVG stenting in which the WIRIONTM system was used.
- Patient is greater than or equal to 18 years of age.
Exclusion Criteria
- Undergone cardiac surgery in the past 60 days before the procedure.
Data sourced from ClinicalTrials.gov (NCT02373852). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.